Panitumumab is a fully human IgG2 monoclonal antibody that specifically binds to and inhibits the epidermal growth factor receptor (EGFR). It is widely used in both in vitro and in vivo research to study EGFR-driven cancers, including colorectal cancer, and to investigate mechanisms of targeted therapy.
Concentration:
19.7 mg/mL
Molecular Weight:
147 kDa
Purity:
99.40% (May vary between batches)
CAS Number:
[339177-26-3]
Target:
EGFR
* VAT and and shipping costs not included. Errors and price changes excepted